Form 483

Argenta US Manufacturing LLC Form 483, 2015-07-30

FDA issued a Form 483 to Argenta US Manufacturing LLC on 2015-07-30 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Argenta US Manufacturing LLC · Shawnee, United States · Issued July 30, 2015

Overview

  • 6 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Jul 2015
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Michele L Obert

30 Jul 2015
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Michele L Obert

30 Jul 2015
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Michele L Obert

30 Jul 2015
21 CFR 211.192

No written record of investigation

Cited by Michele L Obert

30 Jul 2015
21 CFR 211.192

No written record of investigation

Cited by Michele L Obert

Inspected site

AUArgenta US Manufacturing LLCShawnee, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations3x
21 CFR 211.192Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere